Difference between revisions of "WSI21-216-Case-2"

From MGH Learn Pathology
(Automatic edit to upgrade to new templates)
(Updating subject, access, and performer)
Line 11: Line 11:
 
|reasonCode=22 yo with hyperleukocytosis (WBC 78) and anemia (HGB: 9; HCT: 28.5%; MCV:81), concerning for acute myeloid leukemia.
 
|reasonCode=22 yo with hyperleukocytosis (WBC 78) and anemia (HGB: 9; HCT: 28.5%; MCV:81), concerning for acute myeloid leukemia.
 
|subject=MGH
 
|subject=MGH
|performer=Vn048
+
|performer=VN048
 
|authoredOn=December 02, 2021 09:03:06 PM
 
|authoredOn=December 02, 2021 09:03:06 PM
 
|requester=Vn048
 
|requester=Vn048
 
|sequence=2
 
|sequence=2
 +
|access=private
 
}}
 
}}
 
{{Media
 
{{Media

Revision as of 15:06, June 21, 2022

WSI21-216-Case-2
22 yo with hyperleukocytosis (WBC 78) and anemia (HGB: 9; HCT: 28.5%; MCV:81), concerning for acute myeloid leukemia.
Chronic myeloid leukemia, morphologically in chronic phase.
December 8, 2021 12:00:00 AM